Dry%20eye%20syndrome News

News

Perfluorohexyloctane eye drops for dry eye disease impresses in phase III trial

20230325100000

The novel NOV03 ophthalmic drop consisting of perfluorohexyloctane appears to help reduce both signs and symptoms of dry eye disease (DED) associated with meibomian gland dysfunction (MGD), as shown in the results of the phase III MOJAVE study.

Investigational drug for dry eye disease scores high in phase III study

20230101110000

Treatment with the NOV03 (perfluorohexyloctane) ophthalmic drop is well tolerated and yields significant improvements in the signs and symptoms of dry eye disease (DED) associated with meibomian gland dysfunction, according to the results of a phase III study.

Varenicline nasal spray improves bilateral tear production in dry eye disease

20221107060000

Treatment with OC-01 (varenicline solution) nasal spray in patients with dry eye results in a substantial increase in tear production in the study eyes as well as in milder presenting nonstudy fellow eyes, according to data from the ONSET-1* and ONSET-2 trials.

SGLT2 inhibitors potentially protective against dry eye disease

Jairia Dela Cruz, 20220929140000

Type 2 diabetes (T2D) patients on sodium-glucose cotransporter 2 (SGLT2) inhibitors appear to be at lower risk of dry eye disease (DED) compared with their counterparts who are receiving glucagonlike peptide-1 receptor agonists (GLP-1 RAs), as shown in a study.

Dry eye disease: Too much water intake more harmful than beneficial

Jairia Dela Cruz, 20220818140000

Drinking a lot of water does not seem to lower the risk of dry eye disease but may rather contribute to a modest risk increase, as reported in a recent cross-sectional study.

Investigational nasal spray for dry eye disease scores high in phase II trial

20220816180000

The single-dose nicotinic acetylcholine receptor agonist OC-02, administered as an aqueous nasal spray, helps increase tear production and improve eye dryness in patients with dry eye disease (DED), according to data from the phase II PEARL trial.

Thermoelectric warming therapy beneficial in MGD-related dry eye disease

Jairia Dela Cruz, 20220714140000

A device that applies consistent emissive heat to the meibomian glandular apparatus appears to produce significant improvements in the signs and symptoms of dry eye disease in patients with meibomian gland dysfunction (MGD), with the benefits sustained over 6 months following treatment initiation, as shown in a study.

Tear film breakup time tied to choroidal thickness, axial length in kids with DED

20220709180000

In children with dry eye disease (DED) symptoms, there appears to be a significant association between tear film breakup time and choroidal thickness, which in turn is correlated with axial length, a recent study has found.

Omega-3 fatty acids confer no protective effect against dry eye disease

20220628060000

Supplementation with marine ω-3 fatty acids falls short of reducing the incidence of dry eye disease, as shown a study.

Stinging, burning sensation after DED medication use a major concern to patients

Jairia Dela Cruz, 20220627140000

Patients with dry eye disease (DED) can achieve optimal symptom alleviation with available medications, but getting patients to take their medications remains a challenge due to side effects. Taking the burn or sting out of medications might help, according to a Singapore study.

No increased ophthalmic risk with roxadustat treatment in DD CKD-related anaemia

Roshini Claire Anthony, 28 Jun 2020

Roxadustat treatment for anaemia in patients with dialysis-dependent chronic kidney disease (DD CKD) does not come with an increased risk of ophthalmic abnormalities, according to a phase III trial conducted in Japan.

Product Highlight - Bilaxten ODT

16 Mar 2022

Bilastine 10 mg orodispersible tablet

Opacity usually appears later in the development of cataract.

Diagnosing cataract prior to detection of opacity

June Chiang, Ph.D, 26 May 2022

A new algorithm objectively determines when intraocular lens implant (IOL) surgery should be performed, regardless of how the opacity looks to the surgeon.